The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Synaptic Regulation of Mesocorticolimbic Dopamine Neurons
Abstract
The mesocorticolimbic dopamine system is thought to be involved in psychosis and drug addiction. Many intrinsic membrane properties and synaptic regulators have been identified and characterized in the midbrain ventral tegmental dopamine neurons that give rise to this system. Other neuronal properties remain subject to considerable debate. The present review brings together a large literature regarding neurophysiological studies of the synaptic mechanisms thought to regulate the activity of ventral tegmental dopamine neurons. This work is placed within the context of the behavioral responsiveness of midbrain dopamine neurons and the alterations produced in these neurons by repeated treatment with and withdrawal from antipsychotic drugs and drugs of abuse.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given that the majority of afferents onto DA neurons of the VTA -as much as 70 % of synaptic inputs -are GABAergic and have a major impact on the activity of DA cells (Henny et al., 2012; Mathon et al., 2003; White, 1996; Yang et al., 2018)”
From Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer’s Disease (2021) · cites this paper as White, 1996
Citations
Cites
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,133
Stereotaxic mapping of the monoamine pathways in the rat brain
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb10998.x · Cited by 3,819
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,025
Kalivas, P., & Stewart, J. (1991) · Brain research. Brain research reviews · doi:10.1016/0165-0173(91)90007-u · Cited by 2,087
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
Opioids excite dopamine neurons by hyperpolarization of local interneurons
Johnson, S., & North, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00483.1992 · Cited by 1,637
The control of firing pattern in nigral dopamine neurons: burst firing
Grace, A., & Bunney, B. (1984) · Journal of Neuroscience · doi:10.1523/jneurosci.04-11-02877.1984 · Cited by 1,346
Grace, A. A., & Bunney, B. S. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90135-5 · Cited by 937
Chiodo, L. A., & Bunney, B. (1983) · Journal of Neuroscience · doi:10.1523/jneurosci.03-08-01607.1983 · Cited by 680
Gonon, F. G. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90307-7 · Cited by 676
Cited by
Sorted by citations
Items 101–200 of 289
Clinical and therapeutic observations in aromatic l -amino acid decarboxylase deficiency
Swoboda, K. J., Hyland, Κ., Goldstein, D. S., Kuban, K., Arnold, L. A., Holmes, C. S., & Levy, H. L. (1999) · Neurology · doi:10.1212/wnl.53.6.1205 · Cited by 80
Cheer, J. F., Marsden, C. A., Kendall, D. A., & Mason, R. J. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00241-4 · Cited by 77
Stefański, R., Justinová, Z., Hayashi, T., Takebayashi, M., Goldberg, S. R., & Su, T. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1779-9 · Cited by 76
Faleiro, L. J., Jones, S., & Kauer, J. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300495 · Cited by 77
Mesoprefrontal dopaminergic neurons: Can tyrosine availability influence their functions?
Tarn, S.-Y., & Roth, R. H. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00774-5 · Cited by 74
Williams, J. M., & Steketee, J. D. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03618.x · Cited by 74
Effect of stress on prefrontal cortex function
Moghaddam, B., & Jackson, M. (2004) · Neurotoxicity Research · doi:10.1007/bf03033299 · Cited by 73
Giorgetti, M., Hotsenpiller, G., Froestl, W., & Wolf, M. E. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00510-3 · Cited by 72
Bruijnzeel, A. W., Stam, R., Compaan, J. C., Croiset, G., Akkermans, L. M. A., Olivier, B., & Wiegant, V. M. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01350-x · Cited by 72
Differential Effects of Cocaine on Dopamine Neuron Firing in Awake and Anesthetized Rats
Koulchitsky, S., Backer, B. D., Quertemont, É., Charlier, C., & Seutin, V. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.339 · Cited by 70
The role of CART in the reward/reinforcing properties of psychostimulants
Jaworski, J. N., & Jones, D. C. (2006) · Peptides · doi:10.1016/j.peptides.2006.03.034 · Cited by 70
Pharmacogenetic Treatments for Drug Addiction: Alcohol and Opiates
Haile, C. N., Kosten, T. A., & Kosten, T. R. (2008) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990802122564 · Cited by 73
Morphine withdrawal‐induced abnormalities in the VTA: confocal laser scanning microscopy
Spiga, S., Serra, G. P., Puddu, M. C., Foddai, M., & Diana, M. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02435.x · Cited by 69
Multiple mechanisms underlie burst firing in rat midbrain dopamine neurons in vitro
Johnson, S. W., & Wu, Y.-N. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.022 · Cited by 68
Erhardt, A., Sillaber, I., Welt, T., Müller, M. B., Singewald, N., & Keck, M. E. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300493 · Cited by 67
Impulse activity of ventral tegmental area neurons during heroin self-administration in rats
Kiyatkin, E. A., & Rebec, G. V. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00492-9 · Cited by 66
Suto, N., Tanabe, L. M., Austin, J. D., Creekmore, E., & Vezina, P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300075 · Cited by 66
Wolf, M. E., & Xue, C. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731529.x · Cited by 65
Matteo, V. D., Mascio, M. D., Giovanni, G. D., & Esposito, E. (2000) · Psychopharmacology · doi:10.1007/s002130000420 · Cited by 64
Novel Protein Kinase A-Dependent Long-Term Depression of Excitatory Synapses
Gutlerner, J. L., Penick, E. C., Snyder, E. M., & Kauer, J. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)01051-6 · Cited by 64
Godet, A., Fortier, A., Bannier, É., Coquery, N., & Val‐Laillet, D. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09700-x · Cited by 76
Guo, Y., Wang, H., Xiang, X., & Zhao, Y. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.02.005 · Cited by 62
Lü, W. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00272-x · Cited by 63
McClure, M. M., Harvey, P. D., Goodman, M. S., Triebwasser, J., New, A. S., Koenigsberg, H. W., Sprung, L., Flory, J. D., & Siever, L. J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.5 · Cited by 61
Orchestration of synaptic plasticity through AKAP signaling complexes
Bauman, A. L., Goehring, A. S., & Scott, J. D. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.016 · Cited by 62
BDNF Signaling in the VTA Links the Drug-Dependent State to Drug Withdrawal Aversions
Vargas-Pérez, H., Bahí, A., Bufalino, M. R., Ting‐A‐Kee, R. A., Maal‐Bared, G., Lam, J., Fahmy, A., Clarke, L., Blanchard, J. K., Larsen, B., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3776-13.2014 · Cited by 62
Febo, M., Gonzalez-Rodriguez, L. A., Capó‐Ramos, D. E., González‐Segarra, N. Y., & Segarra, A. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01858.x · Cited by 59
Olsson, S. K., Andersson, A., Linderholm, K. R., Holtze, M., Nilsson-Todd, L. K., Schwieler, L., Olsson, E., Larsson, K., Engberg, G., & Erhardt, S. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009383 · Cited by 58
Chefer, V. I., Denoroy, L., Zapata, A. G., & Shippenberg, T. S. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06827.x · Cited by 58
Gao, C., & Wolf, M. E. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2925-07.2007 · Cited by 57
Michaeli, A., & Yaka, R. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.11.045 · Cited by 58
Mathon, D. S., Lesscher, H. M. B., Gerrits, M. A. F. M., Kamal, A., Pintar, J. E., Schuller, A. G., Spruijt, B. M., Burbach, J. P. H., Smidt, M. P., van Ree, J. M., et al. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.10.002 · Cited by 55
Jasinska, A. J., Chen, B. T., Bonci, A., & Stein, E. A. (2014) · Addiction Biology · doi:10.1111/adb.12132 · Cited by 61
Gallo, F., Morale, M. C., Spina-Purrello, V., Tirolo, C., Testa, N., Farinella, Z., Avola, R., Beaudet, A., & Marchetti, B. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000615)36:4 · Cited by 39
Self-citationHahn, J., Tse, T. E., & Levitan, E. S. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-34-10859.2003 · Cited by 55
Ding, Z., Engleman, E. A., Rodd, Z. A., & McBride, W. J. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01665.x · Cited by 54
GABA Modulation of Cocaine Self‐Administration
Roberts, D. C. S., & Brebner, K. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06680.x · Cited by 54
Spiga, S., Lintas, A., Migliore, M., & Diana, M. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00218.x · Cited by 53
Endocannabinoid Signaling in Midbrain Dopamine Neurons: More than Physiology?
Melis, M., & Pistis, M. (2007) · Current Neuropharmacology · doi:10.2174/157015907782793612 · Cited by 53
Straley, M. E., Van Oeffelen, W., Theze, S., Sullivan, A. M., O’Mahony, S. M., Cryan, J. F., & O’Keeffe, G. W. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.06.002 · Cited by 52
Sharifzadeh, M. S., Tavasoli, M., Naghdi, N., Ghanbari, A., Amini, M., & Roghani, A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03454.x · Cited by 51
Maldonado, R. J. (2003) · Springer eBooks · doi:10.1007/978-3-7091-0541-2_1 · Cited by 52
Thiemann, G., VANDERSTELT, M., Petrosino, S., Molleman, A., Marzo, V. D., & Hasenöhrl, R. U. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.09.022 · Cited by 51
Vuong, H. E., Hardi, C. N., Barnes, S., & Brecha, N. C. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3382-15.2015 · Cited by 51
Lu, W., Monteggia, L. M., & Wolf, M. E. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00736.x · Cited by 51
Kiyatkin, E. A. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00283-8 · Cited by 49
Xu, C., & Shen, R.-Y. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29593-8 · Cited by 50
A Behavioral/Systems Approach to the Neuroscience of Drug Addiction
White, F. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03303.2002 · Cited by 49
Self-citationEisenstein, S. A., Bischoff, A. N., Gredysa, D. M., Antenor‐Dorsey, J. A. V., Koller, J. M., Al-Lozi, A. M., Pepino, M. Y., Klein, S., Perlmutter, J. S., Moerlein, S. M., et al. (2015) · Scientific Reports · doi:10.1038/srep11283 · Cited by 50
Cocaine-induced adaptations in metabotropic inhibitory signaling in the mesocorticolimbic system
Hearing, M. C., Zink, A. N., & Wickman, K. (2012) · Reviews in the Neurosciences · doi:10.1515/revneuro-2012-0045 · Cited by 50
Wei, D., Maisonneuve, I. M., Kuehne, M. E., & Glick, S. D. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00527-7 · Cited by 47
Good, C. H., & Lupica, C. R. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.164194 · Cited by 45
Giovanni, G. D., Mascio, M. D., Matteo, V. D., & Esposito, E. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37762-6 · Cited by 44
Nakagawa, T., Suzuki, Y., Nagayasu, K., Kitaichi, M., Shirakawa, H., & Kaneko, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024865 · Cited by 43
Plasticity of Addiction: A Mesolimbic Dopamine Short‐Circuit?
Niehaus, J. L., Cruz‐Bermúdez, N. D., & Kauer, J. A. (2009) · The American Journal on Addictions · doi:10.1080/10550490902925946 · Cited by 42
The Synaptic Pathology of Drug Addiction
van den Oever, M. C., Spijker, S., & Smit, A. B. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_21 · Cited by 43
Hefco, V., Yamada, K., Hefco, A., Hriţcu, L., Tiron, A., Olariu, A., & Nabeshima, T. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02034-x · Cited by 41
Shen, R., & Choong, K.-C. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.021 · Cited by 39
Lu, B. S., & Zee, P. C. (2010) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2010.02.004 · Cited by 40
Vashchinkina, E., Panhelainen, A. E., Vekovischeva, O. Y., Aitta‐aho, T., Ebert, B., Ator, N. A., & Korpi, E. R. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4697-11.2012 · Cited by 39
Wang, H., Zhao, Y., Xiang, X., Wang, H., & Wu, W.-R. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.043 · Cited by 38
Interleukin-2 modulates N-methyl-d-aspartate receptors of native mesolimbic neurons
Ye, J. H., Tao, L., & Zalcman, S. S. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02056-x · Cited by 38
Williams, J. M., & Steketee, J. D. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.09.004 · Cited by 38
Decreased chaos of midbrain dopaminergic neurons after serotonin denervation
Mascio, M. D., Giovanni, G. D., Matteo, V. D., & Esposito, E. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00757-x · Cited by 36
Serotonin/dopamine interaction: Electrophysiological and neurochemical evidence
Deurwaerdère, P. D., Chagraoui, A., & Giovanni, G. D. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.02.001 · Cited by 41
Werkman, T. R., Kruse, C. G., Nievelstein, H. M. N. W., Long, S. K., & Wadman, W. J. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00015-6 · Cited by 35
Atkinson, C. L., Feng, J., & Zhang, D.-Q. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00786.2012 · Cited by 34
Parnaudeau, S., Dongelmans, M. L., Turiault, M., Ambroggi, F., Delbès, A.-S., Cansell, C., Luquet, S. H., Piazza, P., Tronche, F., & Barik, J. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00035 · Cited by 34
Giorgetti, M., Javaid, J. I., Davis, J. M., Costa, E., Guidotti, A., Appel, S. B., & Brodie, M. S. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37763-8 · Cited by 34
Federici, M., Geracitano, R., Tozzi, A., Longone, P., Angelantonio, S. D., Bengtson, C. P., Bernardi, G., & Mercuri, N. B. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.007427 · Cited by 33
Molecular and cellular alterations in the Pitx3-deficient midbrain dopaminergic system
Smits, S. M., Mathon, D. S., Burbach, J. P. H., Ramakers, G. M. J., & Smidt, M. P. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.07.018 · Cited by 33
Koeltzow, T. E., & White, F. J. (2003) · Behavioral Neuroscience · doi:10.1037/0735-7044.117.4.860 · Cited by 32
Self-citationGlutamatergic involvement in psychomotor stimulant action
Rockhold, R. W. (1998) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8833-2_4 · Cited by 32
Electrophysiological Pharmacology of Mesencephalic Dopaminergic Neurons
Diana, M., & Tepper, J. M. (2002) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-06765-9_1 · Cited by 33
Tanabe, L. M., Suto, N., Creekmore, E., Steinmiller, C. L., & Vezina, P. (2004) · Behavioural Pharmacology · doi:10.1097/00008877-200409000-00013 · Cited by 30
EXPERIMENTAL ANALYSES OF GENE‐BRAIN‐BEHAVIOR RELATIONS: SOME NOTES ON THEIR APPLICATION
Kennedy, C. H., Caruso, M., & Thompson, T. I. (2001) · Journal of Applied Behavior Analysis · doi:10.1901/jaba.2001.34-539 · Cited by 30
Baker, R. W., Osman, J. L., & Bodnar, R. J. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00528-7 · Cited by 30
Capriles, N., & Cancela, L. M. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00414-4 · Cited by 30
Dopaminergic Reward Pathways and Effects of Stress
Marinelli, M. (2007) · Elsevier eBooks · doi:10.1016/b978-012370632-4/50006-1 · Cited by 30
Dynamic changes in sensitivity occur during the acute response to cocaine and methylphenidate
Kuczenski, R. T., & Segal, D. S. (1999) · Psychopharmacology · doi:10.1007/s002130051147 · Cited by 29
Pharmacology of the Atypical Antipsychotic Remoxipride, a Dopamine D2Receptor Antagonist
Nadal, R. A. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00199.x · Cited by 29
Jang, J. Y., Jang, M., Kim, S. H., Um, K. B., Kang, Y. K., Kim, H. J., Chung, S., & Park, M. K. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07107.x · Cited by 27
Namba, H., Zheng, Y., Abe, Y., & Nawa, H. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.10.057 · Cited by 27
Ferraro, L., Tomasini, M. C., Fuxé, K., Agnati, L. F., Mazza, R., Tanganelli, S., & Antonelli, T. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.03.006 · Cited by 26
Low-Dose Sarin Exposure Produces Long Term Changes in Brain Neurochemistry of Mice
Oswal, D. P., Garrett, T. L., Morris, M., & Lucot, J. B. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0896-9 · Cited by 25
Narita, M., Takagi, M., Aoki, K., Kuzumaki, N., & Suzuki, T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01784.x · Cited by 25
Detection of Drug Effects on Brain Activity using EEG-P300 with Similar Stimuli
Turnip, A., Esti, K. D., Amri, M. F., Simbolon, A. I., Suhendra, M. A., Iskandar, S., & Wirakusumah, F. F. (2017) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/220/1/012042 · Cited by 25
Tactile stimulation activates dopamine release in the lateral septum
Adams, B. W., & Moghaddam, B. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02473-7 · Cited by 25
Wang, H., Xiang, X., Guo, Y., Wu, W.-R., Cao, D., Wang, H., & Zhao, Y. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.10.017 · Cited by 25
Sticht, M. A., Mitsubata, J., Tucci, M. C., & Leri, F. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2009.10.005 · Cited by 25
Vargas-Pérez, H., Grieder, T. E., Ting‐A‐Kee, R. A., Maal‐Bared, G., Chwalek, M., & van der Kooy, D. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13572 · Cited by 22
κ-Opioid Tolerance and Dependence in Cultures of Dopaminergic Midbrain Neurons
Dalman, F. C., & O’Malley, K. L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05750.1999 · Cited by 21
Davidson, C., Ellinwood, E. H., & Lee, T. H. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00213-0 · Cited by 21
The weaver Mutation Reverses the Function of Dopamine and GABA in Mouse Dopaminergic Neurons
Guatteo, E., Fusco, F. R., Giacomini, P., Bernardi, G., & Mercuri, N. B. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06013.2000 · Cited by 21
Sun, W., Xue, Y.-Q., Huang, Z., & Steketee, J. D. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1812-0 · Cited by 20
Expression of D2 dopamine receptor in the mouse brain
Rani, M., & Kanungo, M. S. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.075 · Cited by 20
Ding, Z., Liu, W., Engleman, E. A., Rodd, Z. A., & McBride, W. J. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.01.004 · Cited by 19
Samson, H. H., & Chappell, A. M. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-199903000-00006 · Cited by 19
Altered Mesolimbic Dopamine System in THC Dependence
Spiga, S., Lintas, A., & Diana, M. (2011) · Current Neuropharmacology · doi:10.2174/157015911795017083 · Cited by 18
Lipski, J., Lin, J. Y., Teo, M.-Y., & van Wyk, M. (2002) · Autonomic Neuroscience · doi:10.1016/s1566-0702(02)00038-3 · Cited by 18
Metadata
- Authors
- White, F. J.
- Corresponding author
- White, F J
- ORCID
- White, F J
- Venue
- Annual Review of Neuroscience
- Publisher
- Annual Reviews
- Published
- 1996-03
- Volume
- 19
- Issue
- 1
- Pages
- 405-436
- ISSN
- 0147-006X (ISSN-L)
- 1545-4126
- OpenAlex
- W2175469462
- Cited by
- 289
- References
- 95
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2022: 3 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 8 · 2016: 6 · 2015: 9 · 2014: 7 · 2013: 1 · 2012: 12
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k02da000207-04, 5r01mh040832-06)
- U.S. Public Health Service
- National Institute of Mental Health (MH-40832)
- National Institute on Drug Abuse (DA-04093, DA00207)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- mesocorticolimbic dopamine system, ventral tegmental area, dopaminergic neurons, synaptic regulation, intrinsic membrane properties, psychosis, drug addiction, antipsychotic drugs, drug withdrawal, behavioral responsiveness, midbrain dopaminergic neurons
- MeSH terms
- Afferent Pathways, Animals, Dopamine, gamma-Aminobutyric Acid, Homeostasis, Humans, Limbic System, Mesencephalon, Neurons, Norepinephrine, Receptors, Dopamine, Serotonin, Substance Withdrawal Syndrome, Synapses, Tegmentum Mesencephali, Antipsychotic Agents, Excitatory Amino Acids, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review